High-frequency (10 kHz) spinal cord stimulation for the treatment of focal, chronic postsurgical neuropathic pain: results from a prospective study in Belgium.
Bart BilletKarel HanssensOlivier De CosterAngela SantosAnand RotteVeerle MinnePublished in: Pain management (2021)
Aim: Chronic postsurgical pain (CPSP) is a common complication of surgery. This study was conducted to evaluate the efficacy and safety of paresthesia-free, 10-kHz spinal cord stimulation (SCS) as a treatment for CPSP. Patients & methods: Subjects in this prospective, single-arm study had an average pain intensity of ≥5 cm on a 10-cm visual analog scale. The subjects who had pain relief of ≥50% (response) with temporary trial stimulation were permanently implanted with 10-kHz SCS and assessed for 1 year. Results: At 12 months, 94% of subjects were responders to 10-kHz SCS, and 88% had pain remission (visual analog scale ≤2.5 cm). Conclusion: The pain relief was durable in CPSP subjects and the safety profile of 10-kHz SCS was as expected. Clinical Trial registration number: VT005076953 (Privacy Commission of Belgium).
Keyphrases
- neuropathic pain
- high frequency
- spinal cord
- transcranial magnetic stimulation
- chronic pain
- spinal cord injury
- clinical trial
- pain management
- ejection fraction
- combination therapy
- end stage renal disease
- newly diagnosed
- study protocol
- open label
- prognostic factors
- high intensity
- rheumatoid arthritis
- peritoneal dialysis
- minimally invasive
- atrial fibrillation
- social media
- phase iii